Concepedia

Carsten Krieg

CK

Statistics

Publications

35

Citations

4.7K

H-Index

27

Active since

2002

Affiliations

University of Zurich(Current)

Medical University of South Carolina

University Hospital of Zurich

MUSC Hollings Cancer Center

SIB Swiss Institute of Bioinformatics

Carsten Krieg is an author at University of Zurich specializing in immunology, life sciences, and medicine.

ORCID

Publications per year

2002–2025

35

Publications

35

Exploiting a natural conformational switch to engineer an interleukin-2 ‘superkine’

Aron M. Levin, D.L. Bates, Aaron M. Ring et al. · Nature · 2012 · 554 citations

, , +14

CyTOF workflow: differential discovery in high-throughput high-dimensional cytometry datasets

Małgorzata Nowicka, Carsten Krieg, Helena L. Crowell et al. · F1000Research · 2019 · 441 citations · Full text

, , +13

ALT-803, an IL-15 superagonist, in combination with nivolumab in patients with metastatic non-small cell lung cancer: a non-randomised, open-label, phase 1b trial

John Wrangle, Vamsidhar Velcheti, Manish R. Patel et al. · The Lancet Oncology · 2018 · 426 citations

, , +12

CyTOF workflow: Differential discovery in high-throughput high-dimensional cytometry datasets

Małgorzata Nowicka, Carsten Krieg, Lukas M. Weber et al. · F1000Research · 2017 · 426 citations · Full text

, , +13

Improved IL-2 immunotherapy by selective stimulation of IL-2 receptors on lymphocytes and endothelial cells

Carsten Krieg, Sven Létourneau, Giuseppe Pantaleo et al. · Proceedings of the National Academy of Sciences · 2010 · 386 citations · Full text

, , +13

1–5 of 35